curasan AG (CUR) - Financial and Strategic SWOT Analysis Review

Date: August 17, 2017
Pages: 33
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: C2AC9AEBC06EN
Leaflet:

Download PDF Leaflet

curasan AG (CUR) - Financial and Strategic SWOT Analysis Review
curasan AG (CUR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

curasan AG (curasan) develops, manufactures and commercializes medical devices in the field of regenerative medicine. The company offers a wide range of synthetic bone substitutes, dental and bone regeneration material products. It offers these products to orthopedic and spinal surgeons, oral and maxillofacial surgeons, and periodontists and dental implantologists in the fields of bone and tissue regeneration, tissue engineering, and wound healing for dental, spinal and orthopedic applications. The company has a research and development, and manufacturing facility in Frankfurt, Germany. The company offers its products through a network of distributors in the Americas, Europe, the Middle East and Asia. curasan is headquartered in Kleinostheim, Germany.

curasan AG Key Recent Developments

Nov 10,2016: Curasan Continues Dynamic Growth in the Third Quarter
Aug 18,2016: curasan accelerates sales growth in the first six months due to rising foreign demand
May 11,2016: curasan posts sales growth in the first quarter
Apr 28,2016: Curasan: Annual results influenced by positive trends in growth regions

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

curasan AG - Key Facts
curasan AG - Key Employees
curasan AG - Key Employee Biographies
curasan AG - Major Products and Services
curasan AG - History
curasan AG - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

curasan AG - Business Description
curasan AG - SWOT Analysis
SWOT Analysis - Overview
curasan AG - Strengths
curasan AG - Weaknesses
curasan AG - Opportunities
curasan AG - Threats
curasan AG - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

curasan AG, Medical Equipment, Deals By Year, 2011 to YTD 2017
curasan AG, Medical Equipment, Deals By Type, 2011 to YTD 2017
curasan AG, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Nov 10, 2016: Curasan Continues Dynamic Growth in the Third Quarter
Aug 18, 2016: curasan accelerates sales growth in the first six months due to rising foreign demand
May 11, 2016: curasan posts sales growth in the first quarter
Apr 28, 2016: Curasan: Annual results influenced by positive trends in growth regions

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

curasan AG, Key Facts
curasan AG, Key Employees
curasan AG, Key Employee Biographies
curasan AG, Major Products and Services
curasan AG, History
curasan AG, Subsidiaries
curasan AG, Key Competitors
curasan AG, Annual Ratios
curasan AG, Annual Ratios (Cont.1)
curasan AG, Annual Ratios (Cont.2)
curasan AG, Medical Equipment, Deals By Year, 2011 to YTD 2017
curasan AG, Medical Equipment, Deals By Type, 2011 to YTD 2017
curasan AG, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

curasan AG, Performance Chart (2012 - 2016)
curasan AG, Ratio Charts
curasan AG, Medical Equipment, Deals By Year, 2011 to YTD 2017
curasan AG, Medical Equipment, Deals by Type, 2011 to YTD 2017

COMPANIES MENTIONED

Integra LifeSciences Holdings Corp
Geistlich Pharma AG
ETEX Corp
Co.don AG
Biotest AG
AlloSource
Skip to top


Ask Your Question

curasan AG (CUR) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: